Shimadzu Corp
TSE:7701
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 779
4 921
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shimadzu Corp
Shimadzu Corp
Income from Continuing Operations
Shimadzu Corp
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shimadzu Corp
TSE:7701
|
Income from Continuing Operations
¥51.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
19%
|
|
|
Keyence Corp
TSE:6861
|
Income from Continuing Operations
¥380.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
Yokogawa Electric Corp
TSE:6841
|
Income from Continuing Operations
¥55.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
Azbil Corp
TSE:6845
|
Income from Continuing Operations
¥30B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Amano Corp
TSE:6436
|
Income from Continuing Operations
¥13.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Horiba Ltd
TSE:6856
|
Income from Continuing Operations
¥33.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Shimadzu Corp
Glance View
Founded in 1875 in Kyoto, Japan, Shimadzu Corporation has developed from a small workshop into a powerhouse of innovation in the fields of analytical and measuring instrumentation. With roots tracing back to Genzo Shimadzu's dedication to craftsmanship and technological progress, the company began its journey focusing on educational physics and chemistry apparatus. Over the years, Shimadzu embraced this core philosophy to expand into diverse industries, effectively transforming itself into a significant player in areas such as life sciences, industrial testing, and environmental analysis. Their entrance into the production of X-ray equipment in the early 1900s marked a pivotal shift, cementing their position as pioneers and ensuring a steady stream of revenue through innovation and specialization. Today, Shimadzu's business strategy lies in leveraging its expertise in scientific technology to create high-quality products that serve various global markets. The company designs and manufactures analytical instruments like chromatographs, spectrometers, and DNA sequencers, which are vital in academic research, pharmaceuticals, and environmental studies. The healthcare sector, for instance, is a significant revenue driver, with Shimadzu providing a range of medical equipment that supports diagnostic and therapeutic procedures. Moreover, their industrial division offers testing and inspection machines crucial for quality assurance in sectors like automotive and aerospace. Through sustained research and development, along with strategic partnerships, Shimadzu ensures a competitive edge and continuous growth in its diverse product lines. This broad yet focused approach not only fortifies its market presence but also ensures its financial success across multiple industries.
See Also
What is Shimadzu Corp's Income from Continuing Operations?
Income from Continuing Operations
51.8B
JPY
Based on the financial report for Sep 30, 2024, Shimadzu Corp's Income from Continuing Operations amounts to 51.8B JPY.
What is Shimadzu Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
19%
Over the last year, the Income from Continuing Operations growth was -4%. The average annual Income from Continuing Operations growth rates for Shimadzu Corp have been 7% over the past three years , 10% over the past five years , and 19% over the past ten years .
You don't have any saved screeners yet
